French anti-avoidance rules entered 2026 in a materially tougher posture, with Conseil d’État jurisprudence sharpening how the tax administration applies controlled foreign company (CFC) attribution and substance tests to structures routed through low‑tax jurisdictions. For CFOs, tax directors, fund managers and in‑house counsel, the practical consequence is clear: structures that relied on formal arrangements rather than genuine economic activity now face a higher risk of reallocation, adjustment and penalty. This article translates the current legal framework into an actionable compliance playbook, covering CFC mechanics, recent case law, a dimension‑by‑dimension comparison with other anti‑abuse measures, remediation timelines, fund‑specific exposures and a step‑by‑step audit response.
The position taken here is deliberate: do not wait for an audit notice to test your substance, because the French anti-avoidance rules reward contemporaneous evidence and punish reconstructed narratives.
The direction of travel is unambiguous. French anti-avoidance rules, as interpreted by recent Conseil d’État decisions and reflected in the administration’s published guidance, increasingly privilege economic reality over legal form. The courts have reinforced that a French parent cannot shelter passive income in a lightly taxed entity abroad unless that entity performs genuine functions, bears real risk and is run by people with the authority to manage it.
The short answer to “what are France’s CFC rules?” is this: where a French resident controls a foreign entity subject to a markedly lower effective tax burden, the profits of that entity can be taxed in France as if earned directly, unless the taxpayer demonstrates that the entity carries on a real economic activity. The relevant statutory framework for enterprises is set out principally in Article 209 B of the Code général des impôts (CGI), with a parallel regime in Article 123 bis CGI applicable to individuals. The evidentiary bar for the substance demonstration is high and continues to be interpreted stringently.
Understanding the French anti-avoidance rules starts with recognising that France operates several overlapping tools. CFC attribution under Article 209 B CGI is one; a general abuse‑of‑law doctrine (abus de droit, Article L. 64 of the Livre des procédures fiscales) and a range of specific anti‑abuse provisions are others. They can apply cumulatively, which is why a single structure can face multiple theories of challenge.
The statutory foundation for the French anti-avoidance rules sits in the Code général des impôts (CGI), accessible via Legifrance, supplemented by the administrative interpretations published in the Bulletin Officiel des Finances Publiques (BOFiP). France’s domestic CFC regime predates, but has been aligned with, the European Union’s Anti‑Tax Avoidance Directive (ATAD), which set a common minimum standard for CFC rules across Member States. Practitioners should read the CGI provisions and BOFiP commentary together: the statute sets the architecture, while BOFiP supplies the administration’s operational positions on thresholds, substance and documentation expectations.
Two questions drive the analysis. First, is there control, France generally requires that the French enterprise hold, directly or indirectly, a sufficient participation (broadly more than half of the shares, voting rights or financial rights, with a lower threshold where a significant portion of the foreign entity is French‑held). Second, is the foreign entity subject to a privileged tax regime, assessed under Article 238 A CGI by comparing its effective foreign tax burden against what the equivalent French tax would have been, the foreign entity being treated as privileged where its tax is materially lower than the French charge would be. Where both conditions are met, the regime can attribute the foreign entity’s profits to the French taxpayer.
The critical escape route is the substance defence: if the foreign entity carries on a genuine economic activity, attribution may be disapplied (a defence that is broader and, within the EU/EEA, more readily available in line with EU law following the Cadbury Schweppes line of authority). “Genuine” is assessed by reference to real staff, real premises, real decision‑making and real risk‑bearing, not by the mere existence of a company and a bank account.
The French anti-avoidance rules do not operate in isolation from transfer pricing. The OECD’s BEPS project, which produced guidance on CFC design and on transfer pricing documentation, frames both areas around a single idea: profits should be taxed where value is created. In practice this means the administration will cross‑check your transfer pricing policy against your CFC position. If your transfer pricing files assert that a low‑tax entity performs significant functions and bears material risk, justifying the margin it retains, but your substance evidence is thin, the two stories collide.
Conversely, if transfer pricing allocates little profit to the foreign entity because it does little, that may reduce the CFC stakes but will not cure a lack of substance for other purposes. Alignment between transfer pricing documentation and CFC analysis is now a baseline expectation, not a refinement.
A significant development for the French anti-avoidance rules is jurisprudential. Recent Conseil d’État decisions have refined the tests the administration and lower courts apply, consistently favouring economic substance and the location of genuine management over documentary form. The practical takeaway is that taxpayers should assume a more searching factual review of where decisions are actually taken.
The first strand of Conseil d’État anti-avoidance reasoning concerns the location of real management and the genuineness of the foreign entity’s activity. The court’s approach emphasises that formal indicators, a registered office, a local director’s signature, minutes drafted abroad, carry little weight where the substantive decisions are demonstrably taken in France or where the foreign entity lacks the human and material resources to perform the functions attributed to it. The legal test, as applied, looks through the paperwork to the economic reality. For taxpayers, the lesson is that substance must be operational, not cosmetic: the people who make the decisions must be where the structure says they are, with the competence and authority to make them.
The full judgment texts are available via the Conseil d’État’s jurisprudence database and should be read before finalising any defence.
A second strand matters especially for investment structures. Where holding and management vehicles sit in low‑tax jurisdictions and perform limited genuine activity, the reasoning in recent Conseil d’État anti-avoidance decisions supports attribution or recharacterisation unless the taxpayer can show a real commercial rationale and real functions. For funds, this means blocker entities, holding companies and management companies cannot rely on jurisdiction of incorporation alone. The court’s willingness to examine who exercises the economically significant functions, investment decisions, risk management, capital allocation, directly affects fund tax structuring and the treatment of profit allocations within the structure.
Assume the administration will test your substance against the court’s standard, not a lenient one. Assume formal documentation that is not matched by operational reality will be discounted. And assume that CFC, transfer pricing and abuse‑of‑law arguments may be advanced together. The safest working position is that any low‑substance, high‑passive‑income entity controlled from France is now a priority remediation candidate.
Readers want a clear view of how CFC attribution differs from France’s other anti‑avoidance tools, so they can prioritise. The table below compares the two dimension by dimension. Our recommendation: use it as a triage tool, not a menu of equally weighted options.
| Dimension | CFC rules (France, Art. 209 B / 123 bis CGI) | Other anti‑avoidance measures (abus de droit / substance‑over‑form / specific anti‑abuse provisions) |
|---|---|---|
| Tax effect | Reallocation of the CFC’s income to the French parent (taxation in France on deemed income) | Varies: disallowance of deductions, recharacterisation of transactions, cancellation of treaty benefits |
| Direct cost | French corporation tax on attributed income, plus interest and penalties | Additional tax, surcharges, and increased VAT/withholding exposures depending on the measure applied |
| Secondary liability / risk | Additional corporate tax and exposure for the French parent; reputational and investor‑reporting effects | Broader risks, including, in cases of serious fraud, criminal exposure; cross‑border treaty implications |
| Timing (when applies) | Typically assessed on yearly returns; can be triggered via audit for open years within the statutory reassessment period, which is extended in cases of fraud | Can be applied during audit; may produce immediate adjustments and faster assessments for abusive practices |
| Enforceability / challenge risk | High, backed by the CGI and Conseil d’État case law; the administration is competent to reallocate profits | Highly variable, requires factual assessment; administrative practice varies and litigation can be protracted |
| Common mitigations | Demonstrate substance (management, employees, commercial activity), align transfer pricing, restructure to reduce passive income | Substance, genuine commercial rationale, contemporaneous documentation, pre‑filing rulings where available |
The decision signal is straightforward. If a structure scores high on passive income and low on substance, treat it as high‑risk and prioritise it for remediation above everything else, the CFC route gives the administration a well‑supported, high‑enforceability path to reallocate profits. If the exposure is instead about artificial transactions or treaty shopping, the general anti‑abuse and specific provisions become more relevant, and the defence pivots to commercial rationale. Where a structure is vulnerable on both fronts, assume the administration will run both arguments and build your evidence accordingly.
Compliance with the French anti-avoidance rules is a programme, not a one‑off exercise. The following phased checklist is the method we recommend to multinationals and funds. Each phase builds the evidentiary foundation the Conseil d’État case law now demands.
Funds face a distinctive set of pressures under the French anti-avoidance rules because their structures often concentrate passive income, dividends, interest, capital gains, in holding vehicles located outside France. Anti-avoidance rules for funds therefore demand particular attention to where investment decisions and management functions genuinely occur.
Three structural features attract scrutiny. First, the management company (Manco) where investment and risk‑management decisions are, or should be, taken, if those decisions are in reality taken in France, a low‑tax Manco is vulnerable. Second, holding companies interposed between the fund and its investments, which may hold passive income with little activity. Third, blocker entities used to shape tax outcomes for investors, which can draw attention where their function is purely fiscal. Each of these should be tested against the substance standard the Conseil d’État has reinforced.
Carried interest and the allocation of profits within a fund structure can create CFC exposure where entitlements accrue in low‑tax entities controlled from France but the value‑creating work is performed by France‑based professionals. The analysis turns on where the economically significant functions sit. If the people generating the returns operate from France, routing the reward through a foreign low‑tax vehicle invites attribution or recharacterisation. The defence, where it exists, rests on demonstrating genuine offshore function and risk, which for many fund teams simply will not be present.
For investor reporting and dealings with the administration, sample disclosure language should state plainly, for example: “The entity performs [describe genuine functions] from [location], with [number] employees exercising decision‑making authority over [activity], and bears the following risks: [list].” Disclosure that asserts substance it cannot evidence is worse than silence; every statement should be supportable.
When the administration opens an audit alleging CFC abuse, the quality of your early response shapes the outcome. The French anti-avoidance rules give the administration strong tools, but the process is procedural and the taxpayer has defined rights and windows to exercise them under the Livre des procédures fiscales.
Take a position rather than hedging. Litigate when your substance evidence is strong, the legal test is genuinely in your favour, and the assessment is large enough that the cost of dispute is justified. Settle when the substance is thin, the facts are unhelpful, and the penalty exposure grows with time. The decisive factors are the strength of contemporaneous evidence, the size of the exposure, the appetite for a multi‑year dispute and the reputational sensitivity of the structure. As a rule of thumb: strong evidence and large exposure favour litigation; weak evidence and escalating penalties favour an early, negotiated resolution.
Because the French anti-avoidance rules are now assessed alongside transfer pricing, documentation is the battleground. The evidence that defeats a CFC claim is largely the same evidence that supports a transfer pricing position: proof that functions, assets and risks sit where profit is reported.
A coherent transfer pricing policy that attributes profit in line with genuine functions reduces CFC exposure and strengthens any defence. Incoherence does the opposite: if transfer pricing documentation claims the foreign entity performs valuable functions to justify its margin, the administration will expect the substance to exist, and will use any shortfall against you under the CFC analysis. Treat the two as a single, consistent story. Where you adjust transfer pricing during remediation, ensure the CFC position moves in step so the files never contradict each other. Note that qualifying large groups are also subject to statutory transfer pricing documentation obligations under French law, and failures carry their own penalties.
Three worked examples illustrate how to apply the French anti-avoidance rules in practice. In each case, the decision flow is the same: test control, test effective tax, then test substance, and remediate where substance fails.
The flowchart logic to operationalise: Is the entity controlled from France? → Is its effective tax burden materially low? → Does it carry on genuine economic activity? If the first two are “yes” and the third is “no”, the entity is high‑risk and should enter remediation immediately.
The clear recommendation for 2026 is to act before an audit forces the issue: the French anti-avoidance rules now reward contemporaneous substance and punish reconstructed narratives, and the Conseil d’État has signalled a more searching factual review of where genuine management and activity actually sit. Start by mapping and risk‑scoring your controlled foreign entities, then build the substance and transfer pricing evidence that will withstand scrutiny, and remediate the hollow structures first. For tailored audit response, restructuring and fund‑specific guidance, contact the International Tax, France team through the Global Law Experts network and the directory of International Tax lawyers in France.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Nicolas Duboille at Sumerson, a member of the Global Law Experts network.
posted 24 minutes ago
posted 41 minutes ago
posted 1 hour ago
posted 1 hour ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
No results available
Find the right Legal Expert for your business
Send welcome message